FDA Urged To Add New Black Box Warning On J&J's Levaquin
The U.S. Food and Drug Administration should slap an additional black box warning on Johnson & Johnson's antibiotic Levaquin because of potential cellular damage that could cause an array of serious...To view the full article, register now.
Already a subscriber? Click here to view full article